BackgroundMany adults with autism spectrum disorder (ASD) remain undiagnosed. Specialist
assessment clinics enable the detection of these cases, but such services are often
overstretched. It has been proposed that unnecessary referrals to these services could
be reduced by prioritizing individuals who score highly on the Autism-Spectrum Quotient
(AQ), a self-report questionnaire measure of autistic traits. However, the ability of
the AQ to predict who will go on to receive a diagnosis of ASD in adults is unclear.MethodWe studied 476 adults, seen consecutively at a national ASD diagnostic referral service
for suspected ASD. We tested AQ scores as predictors of ASD diagnosis made by expert
clinicians according to International Classification of Diseases (ICD)-10 criteria,
informed by the Autism Diagnostic Observation Schedule-Generic (ADOS-G) and Autism
Diagnostic Interview-Revised (ADI-R) assessments.ResultsOf the participants, 73% received a clinical diagnosis of ASD. Self-report AQ scores
did not significantly predict receipt of a diagnosis. While AQ scores provided high
sensitivity of 0.77 [95% confidence interval (CI) 0.72–0.82] and positive predictive
value of 0.76 (95% CI 0.70–0.80), the specificity of 0.29 (95% CI 0.20–0.38) and
negative predictive value of 0.36 (95% CI 0.22–0.40) were low. Thus, 64% of those who
scored below the AQ cut-off were ‘false negatives’ who did in fact have ASD.
Co-morbidity data revealed that generalized anxiety disorder may ‘mimic’ ASD and inflate
AQ scores, leading to false positives.ConclusionsThe AQ's utility for screening referrals was limited in this sample. Recommendations
supporting the AQ's role in the assessment of adult ASD, e.g. UK NICE guidelines, may
need to be reconsidered.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.